RAP2B and metastatic neoplasm: In particular, PSMB4, RUVBL2, and ANKAR (Figure 3B) EV protein levels were increased in patients with metastatic disease, whereas RAP2B, SERPINA12, and IGLV4-69 abundance levels were decreased in the cEVs of patients with metastasis (Figure 3C).